Performance measures for guidelines on preventing opportunistic infections in patients infected with human immunodeficiency virus.

This article serves as a complement to the 1999 US Public Health Service/Infectious Diseases Society of America guidelines on the prevention of opportunistic infections in persons infected with HIV, published in this issue of Clinical Infectious Diseases [1]. A number of performance measures to assess compliance with the guidelines and to aid in their implementation are proposed.

[1]  E. McGlynn,et al.  Quality of Care for Oncologic Conditions and HIV , 2000 .

[2]  H. Amandus,et al.  Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States. , 1999, Journal of acquired immune deficiency syndromes.

[3]  W. Hauck,et al.  Translating Clinical Trial Results into Practice: The Effect of an AIDS Clinical Trial on Prescribed Antiretroviral Therapy for HIV-Infected Pregnant Women , 1999, Annals of Internal Medicine.

[4]  A. Telenti,et al.  The New England Jour nal of Medicine DISCONTINUATION OF PRIMARY PROPHYLAXIS AGAINST PNEUMOCYSTIS CARINII PNEUMONIA IN HIV-1–INFECTED ADULTS TREATED WITH COMBINATION ANTIRETROVIRAL THERAPY , 2022 .

[5]  A. Mocroft,et al.  Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection , 1999, The Lancet.

[6]  J. Ward,et al.  Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. , 1999, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[7]  C. Jaspers,et al.  Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy , 1999, The Lancet.

[8]  D. McCaffrey,et al.  The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. , 1998, The New England journal of medicine.

[9]  D. Levy,et al.  Surveillance for waterborne-disease outbreaks--United States, 1995-1996. , 1998, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[10]  E. McGlynn,et al.  Choosing and evaluating clinical performance measures. , 1998, The Joint Commission journal on quality improvement.

[11]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. , 1998, JAMA.

[12]  J. Oleske,et al.  Guidelines for the use of antiretroviral agents in pediatric HIV infection , 1998 .

[13]  E. McGlynn,et al.  Developing a clinical performance measure. , 1998, American journal of preventive medicine.

[14]  J. Singer,et al.  Adherence to clinical guidelines for the therapeutic management of HIV disease. , 1997, Clinical and investigative medicine. Medecine clinique et experimentale.

[15]  D. Gifford,et al.  Development of a quality of care measurement system for children and adolescents. Methodological considerations and comparisons with a system for adult women. , 1997, Archives of pediatrics & adolescent medicine.

[16]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. , 1997, JAMA.

[17]  Brian T. Austin,et al.  Organizing care for patients with chronic illness. , 1996, The Milbank quarterly.

[18]  J. Montaner,et al.  Adherence to guidelines for the prevention of HIV-related respiratory diseases. , 1996, The European respiratory journal.

[19]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. , 1996, JAMA.

[20]  Douglas D. Richman,et al.  Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel , 1996 .

[21]  T. Koepsell,et al.  Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. , 1996, The New England journal of medicine.

[22]  C Safran,et al.  Guidelines for management of HIV infection with computer-based patient's record , 1995, The Lancet.

[23]  J. Phair,et al.  Indicators for assessment of compliance with quality standards for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  K. Holmes,et al.  USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  J. Eisenberg,et al.  Changing physicians' practices. , 1993, Tobacco control.

[26]  T. Davis,et al.  Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  K. Stephenson,et al.  Clinical experience and choice of drug therapy for human immunodeficiency virus disease. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  G. Robbins.  Editorial Response: Time for a New Paradigm—Optimal Management of Patients with Human Immunodeficiency Virus Infection and AIDS , 1999 .

[29]  Henry J. Kaiser,et al.  Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation. , 1998, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[30]  B. Walker,et al.  Report of the NIH Panel To Define Principles of Therapy of HIV Infection* , 1998, Annals of Internal Medicine.

[31]  W. Reeves,et al.  Members of the USPHS/IDSA Prevention of Opportunistic Infections Working Group , 1997, Annals of Internal Medicine.

[32]  S. Asch,et al.  Developing quality review criteria from standards of care for HIV disease: a framework. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[33]  USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. , 1995, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.